腺病毒载体疫苗诱导的CD8+ T细胞可预防小鼠γ疱疹病毒68型潜伏感染建立
研究开发编码小鼠γ疱疹病毒68型CD8+ T细胞表位并连接T细胞佐剂恒定链的复制缺陷型腺病毒5型载体,发现鼻内接种小鼠在接种后14天可将多次鼻内ID50攻毒建立潜伏感染的风险每次暴露降低81%。保护随时间减弱,但同时经肌内和鼻内异源初免-加强接种可延长免疫应答,提前66天接种的动物显示长期保护强趋势。
要点
- 鼻内接种腺病毒载体疫苗后14天,小鼠每次ID50攻毒建立潜伏感染风险降低81%。
- 保护随时间减弱,异源初免-加强同时经肌内和鼻内接种可延长免疫应答。
- 提前66天接种的动物显示长期保护强趋势,提示CD8+ T细胞可预防潜伏感染建立。
核心结论
- CD8+ T细胞能够预防小鼠γ疱疹病毒68型潜伏感染的建立。
- 保护效力随时间难以维持,但异源初免-加强接种可延长免疫应答并显示长期保护强趋势。
研究设计与样本
- 研究开发编码小鼠γ疱疹病毒68型CD8+ T细胞表位并连接T细胞佐剂恒定链的复制缺陷型腺病毒5型载体。
- 采用小鼠鼻内接种,并以多次鼻内ID50攻毒评估潜伏感染建立风险。
主要发现
- 鼻内接种小鼠在接种后14天,每次暴露建立潜伏感染的风险降低81%。
- 保护随时间减弱。
- 同时经肌内和鼻内异源初免-加强接种可延长免疫应答。
- 提前66天接种的动物显示长期保护强趋势。
关键数值与推荐
- 接种后14天,多次鼻内ID50攻毒下每次暴露建立潜伏感染风险降低81%。
临床怎么用
- 提示CD8+ T细胞臂可作为未来针对HIV和多种疱疹病毒等潜伏人类病毒感染疫苗策略的组成部分。
局限性
- 保护效力难以随时间维持。
- 研究为小鼠概念验证研究,结论外推至人类需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CD8+ T cells are known to control infections, but their role in preventing latent infection from establishing has not been thoroughly investigated. We hypothesized that a potent CD8+ T cell response patrolling the mucosal viral entry points could kill the first infected cells and thereby abrogate the infection before latency is established. To investigate this, replication deficient adenovirus serotype 5 vectors encoding murine γ-herpesvirus-68 CD8+ T cell epitopes linkedto the T cell adjuvant Invariant chain, were developed. We show that intranasal vaccination of mice reduces the risk of establishment of latent infection from multiple intranasal ID50 challenges with murine γ-herpesvirus-68 by 81% per exposure at 14 days post vaccination. Protection waned over time, but immune responses were extended by heterologous prime-boost vaccination applied simultaneously intramuscularly and intranasally, and animals vaccinated 66 days prior to challenge showed a strong trend of long-term protection. Our data provides evidence that CD8+ T cells are able to protect against establishment of latent infection. Although the protective efficacy is difficult to maintain over time, this proof-of-concept study suggests a role for a CD8+ T cell arm in future vaccine strategies against latent human viral infections caused by pathogens such as HIV and multiple herpes virus.
引用
- Boilesen DR, Ragonnaud E, Laursen H, et al. CD8+ T cells induced by adenovirus-vectored vaccine are capable of preventing establishment of latent murine γ-herpesvirus 68 infection. Vaccine. 2019. PMID: 31006497. doi:10.1016/j.vaccine.2019.04.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。